Logos Global Management LP Erasca, Inc. Transaction History
Logos Global Management LP
- $761 Million
- Q4 2024
A detailed history of Logos Global Management LP transactions in Erasca, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 12,500,000 shares of ERAS stock, worth $19.6 Million. This represents 4.12% of its overall portfolio holdings.
Number of Shares
12,500,000
Previous 10,900,000
14.68%
Holding current value
$19.6 Million
Previous $29.8 Million
5.43%
% of portfolio
4.12%
Previous 3.94%
Shares
3 transactions
Others Institutions Holding ERAS
# of Institutions
153Shares Held
221MCall Options Held
10.1KPut Options Held
79.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$30.4 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.7MShares$26.2 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$25.5 Million6.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$19.9 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$19.3 Million1.29% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $192M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...